IgA Nephropathy Latest Advances

Find the Latest Research About IgA Nephropathy

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8718 publications

Intestinal Occludin in patients with IgA Nephropathy.

Intestinal Occludin in patients with IgA Nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: April 14, 2026

Implications of the Concept of Nephron Loss on Precision Management of IgA Nephropathy.

Implications of the Concept of Nephron Loss on Precision Management of IgA Nephropathy.

Journal: Journal of the American Society of Nephrology : JASN
Published: March 31, 2026

NBL1 Associates with Renal Phenotypes in Mice, but Partial Nbl1 Reduction Does Not Ameliorate Kidney Disease.

NBL1 Associates with Renal Phenotypes in Mice, but Partial Nbl1 Reduction Does Not Ameliorate Kidney Disease.

Journal: American journal of physiology. Renal physiology
Published: March 30, 2026

Iptacopan in IgA Nephropathy - Final 24-Month Data.

Iptacopan in IgA Nephropathy - Final 24-Month Data.

Journal: The New England journal of medicine
Published: March 30, 2026

Convergent Proteinuria Reduction across Distinct Therapeutic Pathways in IgA Nephropathy.

Convergent Proteinuria Reduction across Distinct Therapeutic Pathways in IgA Nephropathy.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: March 27, 2026

A Case Series of Elevated Donor-Derived Cell-Free DNA Leading to Diagnosis of Posttransplant Glomerulonephritis.

A Case Series of Elevated Donor-Derived Cell-Free DNA Leading to Diagnosis of Posttransplant Glomerulonephritis.

Journal: Kidney medicine
Published: March 26, 2026

Clinicopathological correlation of Oxford MEST-C scores for IgA nephropathy in native renal biopsies: A single-center study.

Clinicopathological correlation of Oxford MEST-C scores for IgA nephropathy in native renal biopsies: A single-center study.

Journal: Clinical nephrology
Published: March 25, 2026

Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes.

Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 24, 2026

Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? no.

Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? no.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 23, 2026

Efficacy and safety of belimumab in IgA nephropathy: real-world evidence.

Efficacy and safety of belimumab in IgA nephropathy: real-world evidence.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 23, 2026

Stopping an Autoimmune Attack : IgA nephropathy, a frequent cause of kidney failure, is underdiagnosed. New treatments mean it's more important now to find those who will benefit.

Stopping an Autoimmune Attack : IgA nephropathy, a frequent cause of kidney failure, is underdiagnosed. New treatments mean it's more important now to find those who will benefit.

Journal: Scientific American
Published: March 17, 2026

Correction to: Toll-Like Receptor 9 Affects Severity of IgA Nephropathy.

Correction to: Toll-Like Receptor 9 Affects Severity of IgA Nephropathy.

Journal: Journal of the American Society of Nephrology : JASN
Published: March 16, 2026
Showing 1-12 of 8,718

Last Updated: 04/28/2026